INSULIN GLARGINE

INSULIN GLARGINE was reported 250041 times

INSULIN GLARGINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE OPERATIONAL ISSUE 1996 0.4635
1 PULMONARY VASCULITIS 197 0.3662
2 HYPOGLYCAEMIA UNAWARENESS 124 0.3464
3 NEUROLOGIC NEGLECT SYNDROME 183 0.3291
4 PRODUCT STORAGE ISSUE 1191 0.3141
5 TOTAL LUNG CAPACITY ABNORMAL 116 0.2982
6 DIABETIC HYPERGLYCAEMIC COMA 96 0.2945
7 HYPOGLYCAEMIC UNCONSCIOUSNESS 570 0.2876
8 HYPOGLYCAEMIC SEIZURE 232 0.2555
9 SHOCK HYPOGLYCAEMIC 118 0.2479
10 BLOOD GLUCOSE FLUCTUATION 2709 0.2469
11 DIABETIC RETINOPATHY 834 0.2453
12 PRODUCT DISPENSING ISSUE 1011 0.2361
13 CAROTID ARTERY THROMBOSIS 194 0.2285
14 BLOOD GLUCOSE DECREASED 10606 0.2206
15 DIABETIC METABOLIC DECOMPENSATION 303 0.2181
16 BLOOD GLUCOSE ABNORMAL 4024 0.2176
17 HYPOGLYCAEMIC COMA 621 0.2153
18 BLOOD GLUCOSE INCREASED 39496 0.2094
19 DIABETES MELLITUS INADEQUATE CONTROL 3668 0.2070
20 SPIROMETRY ABNORMAL 118 0.1973
21 GLYCOSYLATED HAEMOGLOBIN INCREASED 4966 0.1966
22 MITE ALLERGY 114 0.1740
23 NEUROPATHIC ARTHROPATHY 110 0.1700
24 HYPOGLYCAEMIA 8111 0.1671
25 INSULIN RESISTANCE 338 0.1623
26 ACCIDENTAL UNDERDOSE 2087 0.1449
27 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 173 0.1444
28 ADJUSTMENT DISORDER 186 0.1431
29 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 102 0.1392
30 MYCOTIC ALLERGY 118 0.1380
31 NEURITIS 208 0.1346
32 HYPERGLYCAEMIA 4788 0.1313
33 DIABETIC NEUROPATHY 643 0.1297
34 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 135 0.1271
35 DIABETIC COMA 348 0.1242
36 GLYCOSYLATED HAEMOGLOBIN DECREASED 194 0.1204
37 DRUG ADMINISTERED IN WRONG DEVICE 116 0.1185
38 DUST ALLERGY 116 0.1182
39 DIABETIC FOOT 360 0.1175
40 NEPHROGENIC ANAEMIA 516 0.1113
41 DIABETIC KETOACIDOSIS 2644 0.1100
42 DEVICE DISPENSING ERROR 125 0.1058
43 HYPERPARATHYROIDISM SECONDARY 260 0.1037
44 PRODUCT STORAGE ERROR 8960 0.1022
45 RETINOPATHY 369 0.0988
46 WRONG DRUG ADMINISTERED 878 0.0984
47 DIABETIC COMPLICATION 250 0.0981
48 KETOACIDOSIS 704 0.0940
49 GASTROINTESTINAL HYPOMOTILITY 198 0.0878
50 GANGRENE 522 0.0865
51 DIABETIC NEPHROPATHY 190 0.0862
52 INJURY ASSOCIATED WITH DEVICE 1718 0.0843
53 CONJUNCTIVITIS ALLERGIC 121 0.0816
54 FOOT AMPUTATION 118 0.0810
55 LEG AMPUTATION 333 0.0807
56 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 163 0.0799
57 ADENOCARCINOMA PANCREAS 102 0.0794
58 DEVICE MECHANICAL ISSUE 1078 0.0785
59 MULTIPLE USE OF SINGLE-USE PRODUCT 439 0.0781
60 MULTI-ORGAN DISORDER 150 0.0762
61 RESPIRATORY SYMPTOM 215 0.0755
62 INCORRECT PRODUCT STORAGE 966 0.0734
63 TOE AMPUTATION 373 0.0734
64 PERSONALITY DISORDER 190 0.0725
65 VISUAL IMPAIRMENT 8954 0.0722
66 IMPAIRED GASTRIC EMPTYING 963 0.0706
67 EYE HAEMORRHAGE 942 0.0705
68 PRODUCT DISPENSING ERROR 1518 0.0696
69 SYSTEMIC INFECTION 110 0.0663
70 PANCREATIC CARCINOMA METASTATIC 186 0.0653
71 EARLY SATIETY 116 0.0595
72 RENAL TRANSPLANT 214 0.0592
73 CATARACT OPERATION 351 0.0591
74 WRONG PATIENT RECEIVED PRODUCT 172 0.0587
75 END STAGE RENAL DISEASE 1068 0.0585
76 ARTERIAL OCCLUSIVE DISEASE 455 0.0578
77 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10398 0.0576
78 EUGLYCAEMIC DIABETIC KETOACIDOSIS 237 0.0573
79 PANCREATIC DISORDER 280 0.0568
80 CATARACT 3331 0.0559
81 NORMOCHROMIC NORMOCYTIC ANAEMIA 168 0.0559
82 MACULAR DEGENERATION 657 0.0550
83 REBOUND ACID HYPERSECRETION 166 0.0548
84 ESSENTIAL HYPERTENSION 98 0.0535
85 VASCULAR GRAFT 149 0.0517
86 EYE OPERATION 237 0.0514
87 VISUAL ACUITY REDUCED 1699 0.0511
88 DRUG ADMINISTRATION ERROR 1554 0.0506
89 INJECTION SITE INJURY 279 0.0503
90 FORCED EXPIRATORY VOLUME DECREASED 141 0.0497
91 RETINAL DISORDER 129 0.0495
92 HYPOACUSIS 2133 0.0495
93 BLINDNESS UNILATERAL 683 0.0484
94 TYPE 1 DIABETES MELLITUS 285 0.0473
95 BLINDNESS 1898 0.0465
96 INJECTION SITE SCAR 131 0.0459
97 WRONG PRODUCT ADMINISTERED 305 0.0451
98 RENAL FAILURE CHRONIC 342 0.0444
99 PANCREATITIS CHRONIC 105 0.0443
100 CARDIAC OPERATION 372 0.0432
101 INTERCEPTED PRODUCT STORAGE ERROR 154 0.0431
102 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2005 0.0429
103 DEVICE ISSUE 3720 0.0414
104 SENSORY LOSS 327 0.0406
105 HEMIPLEGIA 333 0.0400
106 VITREOUS HAEMORRHAGE 110 0.0398
107 GLAUCOMA 760 0.0394
108 PULMONARY ALVEOLAR HAEMORRHAGE 221 0.0394
109 DEVICE DEFECTIVE 672 0.0387
110 WHEELCHAIR USER 172 0.0387
111 NEUROLOGICAL SYMPTOM 217 0.0379
112 INCORRECT DOSE ADMINISTERED BY DEVICE 985 0.0375
113 DEVICE MALFUNCTION 2617 0.0372
114 CORONARY ARTERY BYPASS 214 0.0372
115 RETINAL DETACHMENT 340 0.0369
116 EYE DISORDER 1215 0.0369
117 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 201 0.0369
118 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 149 0.0365
119 EXPOSURE VIA SKIN CONTACT 943 0.0364
120 ARTERIOSCLEROSIS 342 0.0363
121 DIALYSIS 514 0.0362
122 HEARING IMPAIRED 217 0.0361
123 PERIPHERAL VASCULAR DISORDER 186 0.0361
124 ARTERIOSCLEROSIS CORONARY ARTERY 238 0.0359
125 CAROTID ARTERY OCCLUSION 131 0.0359
126 DISABILITY 682 0.0345
127 CHRONIC KIDNEY DISEASE 2575 0.0339
128 INTENTIONAL DEVICE MISUSE 148 0.0335
129 RETINAL HAEMORRHAGE 238 0.0334
130 HUNGER 465 0.0333
131 HYPERKALAEMIA 1170 0.0333
132 LACTIC ACIDOSIS 1072 0.0331
133 ISCHAEMIC CARDIOMYOPATHY 101 0.0329
134 ANGIOPATHY 182 0.0324
135 WOUND COMPLICATION 111 0.0323
136 CORONARY ARTERY OCCLUSION 442 0.0322
137 INJECTION SITE HAEMORRHAGE 2573 0.0322
138 DEMENTIA 892 0.0319
139 HAEMORRHAGIC ANAEMIA 139 0.0316
140 PRODUCT DOSE OMISSION 2060 0.0315
141 DEVICE USE ISSUE 551 0.0315
142 MALNUTRITION 349 0.0312
143 OBSTRUCTIVE AIRWAYS DISORDER 347 0.0312
144 NEPHROPATHY 290 0.0310
145 EXPIRED PRODUCT ADMINISTERED 1032 0.0310
146 UNDERDOSE 2266 0.0310
147 RENAL DISORDER 1443 0.0309
148 LEFT VENTRICULAR HYPERTROPHY 132 0.0308
149 LOCALISED INFECTION 735 0.0304
150 STENT PLACEMENT 245 0.0304
151 INCORRECT DOSE ADMINISTERED 6933 0.0303
152 HYPOVOLAEMIA 176 0.0300
153 INJECTION SITE NODULE 331 0.0300
154 DRUG DISPENSING ERROR 459 0.0300
155 RENAL FAILURE 3927 0.0295
156 ABSCESS LIMB 126 0.0295
157 EXPIRED DRUG ADMINISTERED 146 0.0295
158 THYROID DISORDER 453 0.0294
159 NECROTISING FASCIITIS 103 0.0292
160 ACUTE KIDNEY INJURY 4373 0.0285
161 BLOOD POTASSIUM INCREASED 459 0.0282
162 TRIGGER FINGER 115 0.0281
163 INJECTION SITE EXTRAVASATION 342 0.0277
164 CEREBROVASCULAR ACCIDENT 4593 0.0271
165 PRODUCT TEMPERATURE EXCURSION ISSUE 139 0.0270
166 OVERWEIGHT 145 0.0270
167 MOTOR DYSFUNCTION 275 0.0270
168 VASCULITIS 308 0.0264
169 OSTEOMYELITIS 475 0.0262
170 POOR PERIPHERAL CIRCULATION 111 0.0260
171 CARDIAC FAILURE CONGESTIVE 2081 0.0259
172 BACK DISORDER 417 0.0256
173 ANGINA PECTORIS 725 0.0253
174 SPINAL COLUMN STENOSIS 119 0.0252
175 POLYURIA 206 0.0251
176 CYSTIC FIBROSIS 139 0.0251
177 UROSEPSIS 231 0.0250
178 CORONARY ARTERY DISEASE 747 0.0246
179 LIMB INJURY 669 0.0246
180 SKIN HAEMORRHAGE 365 0.0246
181 DECUBITUS ULCER 198 0.0243
182 SKIN ULCER 625 0.0242
183 GLOMERULAR FILTRATION RATE DECREASED 297 0.0241
184 INTENTIONAL PRODUCT MISUSE 2111 0.0241
185 HYPERKERATOSIS 133 0.0241
186 PANCREATITIS ACUTE 539 0.0240
187 INJECTION SITE BRUISING 1908 0.0239
188 ANGINA UNSTABLE 155 0.0238
189 DIABETES MELLITUS 1810 0.0237
190 COORDINATION ABNORMAL 331 0.0237
191 DRUG DOSE OMISSION 3920 0.0237
192 HEMIPARESIS 400 0.0236
193 WALKING AID USER 155 0.0235
194 ERUCTATION 454 0.0234
195 RENAL TUBULAR NECROSIS 230 0.0234
196 CARPAL TUNNEL SYNDROME 327 0.0233
197 HEPATIC ENCEPHALOPATHY 217 0.0232
198 WEIGHT DECREASED 6464 0.0231
199 POOR QUALITY DRUG ADMINISTERED 149 0.0230
200 MACULAR OEDEMA 129 0.0230
201 EATING DISORDER 490 0.0230
202 ANKLE FRACTURE 354 0.0228
203 CARDIAC PACEMAKER INSERTION 136 0.0228
204 GENERALISED OEDEMA 282 0.0228
205 COLD SWEAT 400 0.0227
206 VISUAL DISTURBANCE 130 0.0226
207 ARTHRITIS 1778 0.0226
208 INJECTION SITE DISCOLOURATION 282 0.0225
209 HYPERLIPIDAEMIA 268 0.0224
210 ESCHERICHIA URINARY TRACT INFECTION 95 0.0223
211 PANCREATITIS 1180 0.0223
212 DYSLIPIDAEMIA 113 0.0222
213 SINUS CONGESTION 300 0.0222
214 FULL BLOOD COUNT ABNORMAL 234 0.0221
215 INJECTION SITE MASS 818 0.0221
216 LIMB OPERATION 106 0.0221
217 THIRST 393 0.0220
218 CARDIAC VALVE DISEASE 125 0.0218
219 BLINDNESS TRANSIENT 161 0.0218
220 PHARMACEUTICAL PRODUCT COMPLAINT 565 0.0217
221 UPPER LIMB FRACTURE 431 0.0216
222 RENAL FAILURE ACUTE 917 0.0216
223 HEPATIC CIRRHOSIS 404 0.0215
224 ABDOMINAL HERNIA 98 0.0215
225 PANCREATIC CARCINOMA 620 0.0214
226 KIDNEY TRANSPLANT REJECTION 103 0.0214
227 NEUROPATHY PERIPHERAL 2023 0.0212
228 INJECTION SITE PAIN 6515 0.0212
229 HYPERHIDROSIS 2727 0.0211
230 GOUT 378 0.0210
231 FOOT FRACTURE 397 0.0209
232 SINUS DISORDER 414 0.0209
233 SOPOR 275 0.0207
234 SLEEP APNOEA SYNDROME 395 0.0207
235 AFFECT LABILITY 199 0.0207
236 FRUSTRATION TOLERANCE DECREASED 166 0.0205
237 LOSS OF CONSCIOUSNESS 2629 0.0205
238 METABOLIC ACIDOSIS 654 0.0204
239 INJECTION SITE DISCOMFORT 215 0.0204
240 PYELONEPHRITIS 177 0.0204
241 BLOOD UREA INCREASED 342 0.0204
242 ACIDOSIS 156 0.0204
243 CARDIAC DISORDER 1902 0.0203
244 PRODUCT USE ISSUE 3819 0.0203
245 HEPATIC STEATOSIS 378 0.0203
246 CELLULITIS 1019 0.0202
247 CORONARY ARTERY STENOSIS 101 0.0201
248 ACUTE CORONARY SYNDROME 166 0.0200
249 RENAL INJURY 595 0.0200
250 ACUTE RESPIRATORY FAILURE 385 0.0200
251 HYPERTRIGLYCERIDAEMIA 117 0.0200
252 MEMORY IMPAIRMENT 2744 0.0200
253 DEHYDRATION 2655 0.0199
254 AMMONIA INCREASED 101 0.0198
255 TRANSIENT ISCHAEMIC ATTACK 665 0.0197
256 PULMONARY OEDEMA 881 0.0197
257 KLEBSIELLA INFECTION 99 0.0196
258 NERVE INJURY 216 0.0194
259 CORONARY ARTERIAL STENT INSERTION 98 0.0193
260 MYOCARDIAL INFARCTION 3369 0.0193
261 ROAD TRAFFIC ACCIDENT 807 0.0193
262 ACUTE MYOCARDIAL INFARCTION 568 0.0192
263 INCOHERENT 124 0.0191
264 BACK INJURY 208 0.0191
265 INCORRECT PRODUCT ADMINISTRATION DURATION 414 0.0191
266 PULMONARY FIBROSIS 366 0.0191
267 ELECTROLYTE IMBALANCE 221 0.0190
268 HYPERVOLAEMIA 94 0.0190
269 RESPIRATORY TRACT CONGESTION 302 0.0190
270 BLOOD PRESSURE DIASTOLIC DECREASED 140 0.0189
271 LOWER LIMB FRACTURE 364 0.0189
272 PHARYNGITIS 235 0.0189
273 CYSTITIS 601 0.0189
274 DEAFNESS UNILATERAL 104 0.0189
275 FALL 6260 0.0188
276 NERVOUSNESS 978 0.0187
277 NODULE 243 0.0186
278 SNEEZING 417 0.0186
279 FLANK PAIN 173 0.0184
280 RENAL IMPAIRMENT 1548 0.0184
281 NERVE COMPRESSION 170 0.0184
282 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 954 0.0183
283 ROTATOR CUFF SYNDROME 234 0.0182
284 POOR QUALITY PRODUCT ADMINISTERED 192 0.0182
285 LIMB DISCOMFORT 560 0.0181
286 APHASIA 546 0.0181
287 BLOOD MAGNESIUM DECREASED 155 0.0179
288 ATRIAL FLUTTER 143 0.0179
289 TREMOR 2974 0.0179
290 MEDICATION ERROR 992 0.0178
291 TUBULOINTERSTITIAL NEPHRITIS 333 0.0177
292 MOUTH HAEMORRHAGE 130 0.0177
293 DYSARTHRIA 667 0.0177
294 GAIT INABILITY 592 0.0177
295 BLOOD TRIGLYCERIDES INCREASED 312 0.0176
296 FLUID RETENTION 897 0.0176
297 HEAD INJURY 557 0.0176
298 HIP FRACTURE 566 0.0176
299 MUSCLE SPASTICITY 216 0.0176
300 FLUID OVERLOAD 255 0.0175
301 OEDEMA PERIPHERAL 2133 0.0175
302 PRODUCT QUALITY ISSUE 2368 0.0174
303 POLLAKIURIA 727 0.0174
304 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 296 0.0174
305 INTERVERTEBRAL DISC PROTRUSION 381 0.0174
306 WEIGHT INCREASED 3889 0.0173
307 PRESYNCOPE 422 0.0173
308 LOWER GASTROINTESTINAL HAEMORRHAGE 128 0.0173
309 OFF LABEL USE 15116 0.0172
310 INFARCTION 118 0.0172
311 PEMPHIGOID 130 0.0172
312 HAND FRACTURE 122 0.0172
313 POST PROCEDURAL INFECTION 140 0.0172
314 LYMPHOEDEMA 119 0.0172
315 SCIATICA 274 0.0172
316 LARGE INTESTINE POLYP 119 0.0172
317 WOUND 480 0.0172
318 VISION BLURRED 2354 0.0171
319 DECREASED APPETITE 3959 0.0170
320 HYPOTHERMIA 172 0.0170
321 LIPASE INCREASED 130 0.0169
322 HAEMOPTYSIS 472 0.0169
323 CONFUSIONAL STATE 2733 0.0169
324 BEDRIDDEN 222 0.0169
325 BRAIN INJURY 169 0.0168
326 ATRIOVENTRICULAR BLOCK 130 0.0168
327 CONCUSSION 130 0.0168
328 ANOREXIA 216 0.0167
329 HYPOTHYROIDISM 535 0.0167
330 JOINT INJURY 357 0.0167
331 OBESITY 266 0.0167
332 CLOSTRIDIUM DIFFICILE COLITIS 177 0.0167
333 CARDIAC FAILURE ACUTE 111 0.0166
334 PERICARDIAL EFFUSION 385 0.0166
335 BLOOD PRESSURE ABNORMAL 330 0.0166
336 APPETITE DISORDER 110 0.0166
337 POSTOPERATIVE WOUND INFECTION 112 0.0166
338 IRON DEFICIENCY ANAEMIA 153 0.0166
339 COMA 789 0.0166
340 ATELECTASIS 160 0.0165
341 MULTIPLE INJURIES 104 0.0165
342 LIQUID PRODUCT PHYSICAL ISSUE 120 0.0164
343 STAPHYLOCOCCAL INFECTION 542 0.0164
344 CHOLECYSTITIS 195 0.0164
345 KIDNEY INFECTION 321 0.0163
346 BLOOD PRESSURE SYSTOLIC INCREASED 319 0.0163
347 HYPOXIA 570 0.0162
348 HYPERTENSIVE CRISIS 179 0.0161
349 INJECTION SITE INDURATION 208 0.0160
350 UNRESPONSIVE TO STIMULI 414 0.0160
351 HAEMORRHAGE 1676 0.0160
352 WEIGHT FLUCTUATION 167 0.0159
353 HAEMORRHAGIC STROKE 124 0.0159
354 CHOLELITHIASIS 520 0.0158
355 ORTHOSTATIC HYPOTENSION 276 0.0158
356 CARDIAC FAILURE 1272 0.0158
357 BLOOD CREATININE INCREASED 1032 0.0158
358 LUNG DISORDER 772 0.0157
359 TOOTHACHE 285 0.0157
360 INABILITY TO AFFORD MEDICATION 156 0.0157
361 ACCIDENT 187 0.0156
362 MYOPATHY 135 0.0156
363 PARALYSIS 223 0.0156
364 INTERVERTEBRAL DISC DEGENERATION 144 0.0155
365 FEELING JITTERY 296 0.0155
366 LEFT VENTRICULAR DYSFUNCTION 104 0.0155
367 SEPSIS 1731 0.0155
368 MENTAL STATUS CHANGES 430 0.0155
369 RIB FRACTURE 318 0.0154
370 HYPOPHAGIA 394 0.0154
371 TROPONIN INCREASED 117 0.0154
372 MALAISE 6724 0.0153
373 CHOLANGITIS 95 0.0153
374 BLOOD CALCIUM DECREASED 172 0.0153
375 ELECTROCARDIOGRAM ABNORMAL 120 0.0153
376 VITREOUS FLOATERS 150 0.0152
377 LEUKOCYTOSIS 276 0.0152
378 BRAIN NEOPLASM 140 0.0152
379 SHOCK HAEMORRHAGIC 124 0.0152
380 ATRIAL FIBRILLATION 1478 0.0152
381 BLOOD POTASSIUM DECREASED 456 0.0152
382 PRODUCT PRESCRIBING ISSUE 330 0.0151
383 CEREBRAL DISORDER 112 0.0151
384 PULMONARY MASS 225 0.0151
385 CHOLESTASIS 290 0.0151
386 WOUND INFECTION 165 0.0151
387 HEPATOMEGALY 148 0.0150
388 HAEMATOMA 389 0.0150
389 ANURIA 129 0.0150
390 URINARY TRACT INFECTION 2553 0.0150
391 CARDIOMEGALY 184 0.0149
392 EXTRASYSTOLES 104 0.0149
393 ABASIA 368 0.0149
394 SPEECH DISORDER 780 0.0149
395 DYSGRAPHIA 98 0.0149
396 LEUKAEMIA 140 0.0148
397 TYPE 2 DIABETES MELLITUS 499 0.0148
398 NEEDLE ISSUE 430 0.0148
399 INTERNATIONAL NORMALISED RATIO INCREASED 418 0.0146
400 HAEMODIALYSIS 123 0.0146
401 DISORIENTATION 580 0.0146
402 ALTERED STATE OF CONSCIOUSNESS 317 0.0146
403 ECONOMIC PROBLEM 221 0.0146
404 CARDIAC MURMUR 126 0.0145
405 INCREASED APPETITE 278 0.0145
406 ASTHENIA 5454 0.0145
407 BODY TEMPERATURE DECREASED 142 0.0144
408 EMPHYSEMA 145 0.0144
409 RENAL CYST 114 0.0143
410 SLUGGISHNESS 146 0.0143
411 DEAFNESS 373 0.0143
412 DIVERTICULUM 101 0.0142
413 HYPERCHOLESTEROLAEMIA 137 0.0142
414 OEDEMA 769 0.0142
415 GAIT DISTURBANCE 2711 0.0142
416 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 125 0.0141
417 VISUAL FIELD DEFECT 102 0.0141
418 LIGAMENT SPRAIN 139 0.0140
419 MITRAL VALVE INCOMPETENCE 159 0.0140
420 ACCIDENTAL EXPOSURE TO PRODUCT 1446 0.0140
421 UPPER GASTROINTESTINAL HAEMORRHAGE 236 0.0140
422 COLON CANCER 208 0.0139
423 FEELING ABNORMAL 3344 0.0139
424 ILEUS 173 0.0139
425 SPINAL OSTEOARTHRITIS 122 0.0139
426 MUSCULAR WEAKNESS 1578 0.0139
427 SUBARACHNOID HAEMORRHAGE 141 0.0138
428 GASTROENTERITIS 202 0.0138
429 ANAEMIA 2633 0.0138
430 GASTROINTESTINAL HAEMORRHAGE 1150 0.0137
431 SINUS BRADYCARDIA 133 0.0137
432 SYNCOPE 1376 0.0137
433 SCAR 235 0.0137
434 HYPOMAGNESAEMIA 191 0.0137
435 URINARY INCONTINENCE 406 0.0137
436 RENAL PAIN 145 0.0137
437 RHABDOMYOLYSIS 570 0.0137
438 VOMITING 6418 0.0136
439 ENCEPHALOPATHY 335 0.0136
440 PRURITUS GENERALISED 295 0.0136
441 HYPERTENSION 2880 0.0136
442 EOSINOPHILIA 238 0.0136
443 PRODUCT ODOUR ABNORMAL 142 0.0135
444 MYOCARDIAL ISCHAEMIA 154 0.0135
445 GALLBLADDER DISORDER 241 0.0135
446 CHEST PAIN 2499 0.0135
447 COVID-19 PNEUMONIA 159 0.0135
448 VITAMIN D DEFICIENCY 131 0.0134
449 DEVICE FAILURE 204 0.0134
450 INJECTION SITE HAEMATOMA 194 0.0134
451 HYPOKALAEMIA 616 0.0133
452 KNEE OPERATION 131 0.0133
453 ABDOMINAL DISTENSION 1390 0.0133
454 INTERNAL HAEMORRHAGE 152 0.0133
455 DYSSTASIA 388 0.0133
456 PERIPHERAL SWELLING 2045 0.0133
457 DYSPEPSIA 1305 0.0133
458 BLOOD PRESSURE INCREASED 2024 0.0132
459 TRICUSPID VALVE INCOMPETENCE 105 0.0132
460 PRODUCTIVE COUGH 630 0.0132
461 MOBILITY DECREASED 948 0.0132
462 WRIST FRACTURE 158 0.0132
463 PRODUCT PRESCRIBING ERROR 313 0.0131
464 DYSPNOEA EXERTIONAL 494 0.0131
465 DIZZINESS POSTURAL 127 0.0131
466 BLADDER DISORDER 130 0.0131
467 SUBDURAL HAEMATOMA 187 0.0131
468 TOOTH FRACTURE 144 0.0130
469 BALANCE DISORDER 1129 0.0130
470 HYPOKINESIA 189 0.0130
471 BRONCHITIS 963 0.0130
472 ANAL INCONTINENCE 117 0.0130
473 LACERATION 122 0.0130
474 HAEMATURIA 444 0.0130
475 NEPHROLITHIASIS 594 0.0129
476 DEVICE LEAKAGE 561 0.0129
477 ACCIDENTAL OVERDOSE 473 0.0129
478 HYPONATRAEMIA 726 0.0129
479 ISCHAEMIC STROKE 230 0.0129
480 PNEUMONIA 4170 0.0129
481 GENERAL PHYSICAL HEALTH DETERIORATION 1488 0.0128
482 PELVIC FRACTURE 100 0.0128
483 FUNGAL INFECTION 428 0.0128
484 HOSPITALISATION 1970 0.0128
485 URINE OUTPUT DECREASED 112 0.0128
486 GASTRITIS 337 0.0128
487 SPINAL DISORDER 121 0.0128
488 MELAENA 280 0.0127
489 AMNESIA 826 0.0127
490 NAUSEA 10036 0.0127
491 IMPAIRED HEALING 416 0.0127
492 THROMBOSIS 1018 0.0126
493 BLADDER CANCER 745 0.0126
494 BACTERAEMIA 150 0.0126
495 DYSURIA 465 0.0126
496 PULMONARY HYPERTENSION 263 0.0126
497 KNEE ARTHROPLASTY 265 0.0126
498 MUSCULOSKELETAL DISCOMFORT 216 0.0125
499 TREATMENT NONCOMPLIANCE 686 0.0125
500 MYOCLONUS 149 0.0125
501 VENTRICULAR TACHYCARDIA 206 0.0125
502 DISCOMFORT 761 0.0125
503 BLOOD IRON DECREASED 148 0.0125
504 ABDOMINAL PAIN UPPER 2562 0.0124
505 CONSTIPATION 2711 0.0124
506 SCRATCH 131 0.0124
507 HYPOTENSION 2481 0.0124
508 ARTHROPATHY 685 0.0123
509 GASTROOESOPHAGEAL REFLUX DISEASE 992 0.0123
510 BLOOD SODIUM DECREASED 232 0.0123
511 DIZZINESS 6129 0.0123
512 UNEVALUABLE EVENT 928 0.0123
513 SPINAL OPERATION 151 0.0122
514 PAIN IN EXTREMITY 3609 0.0122
515 LIVER DISORDER 543 0.0122
516 FURUNCLE 97 0.0122
517 FLATULENCE 692 0.0122
518 RECTAL HAEMORRHAGE 524 0.0122
519 GASTROENTERITIS VIRAL 220 0.0122
520 COUGH 3407 0.0121
521 CONTUSION 1168 0.0121
522 FEEDING DISORDER 246 0.0121
523 LUNG INFILTRATION 107 0.0121
524 HAEMATEMESIS 307 0.0121
525 DEPRESSED LEVEL OF CONSCIOUSNESS 479 0.0121
526 OSTEOARTHRITIS 513 0.0121
527 INFLUENZA 1349 0.0121
528 DRUG PRESCRIBING ERROR 232 0.0121
529 TACHYPNOEA 164 0.0120
530 NEOPLASM MALIGNANT 805 0.0120
531 BLOOD CHOLESTEROL INCREASED 562 0.0120
532 DRUG INTERACTION 1912 0.0120
533 NOCTURIA 146 0.0120
534 PRODUCT ADMINISTRATION ERROR 243 0.0120
535 SEPTIC SHOCK 522 0.0120
536 ILLNESS 1235 0.0120
537 WHEEZING 710 0.0120
538 BLOOD CALCIUM INCREASED 105 0.0120
539 SPLENOMEGALY 140 0.0119
540 MASS 167 0.0119
541 EXOSTOSIS 109 0.0119
542 HAEMATOCRIT DECREASED 236 0.0119
543 CEREBRAL INFARCTION 290 0.0119
544 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2404 0.0119
545 RASH GENERALISED 307 0.0118
546 ASCITES 348 0.0118
547 HAEMOLYTIC ANAEMIA 106 0.0118
548 HYPERSOMNIA 339 0.0118
549 ESCHERICHIA INFECTION 97 0.0118
550 EXTRA DOSE ADMINISTERED 477 0.0118
551 RETCHING 251 0.0118
552 FEAR 315 0.0117
553 FEELING COLD 326 0.0117
554 CARDIOMYOPATHY 173 0.0117
555 SUPRAVENTRICULAR TACHYCARDIA 112 0.0117
556 MUSCLE STRAIN 101 0.0117
557 BRADYCARDIA 619 0.0117
558 CHOLECYSTECTOMY 133 0.0116
559 HEART RATE IRREGULAR 262 0.0116
560 SEASONAL ALLERGY 164 0.0116
561 SPINAL FRACTURE 232 0.0116
562 SURGERY 678 0.0116
563 DEVICE DELIVERY SYSTEM ISSUE 316 0.0115
564 INCONTINENCE 122 0.0115
565 RESPIRATORY FAILURE 838 0.0115
566 DIPLOPIA 298 0.0115
567 TRANSFUSION 120 0.0114
568 PALPITATIONS 1341 0.0114
569 INTENTIONAL PRODUCT USE ISSUE 1003 0.0114
570 FACIAL PAIN 102 0.0114
571 EYE INFECTION 129 0.0114
572 PLEURAL EFFUSION 695 0.0114
573 TENDERNESS 119 0.0114
574 JAUNDICE 307 0.0114
575 POST PROCEDURAL COMPLICATION 219 0.0114
576 DIARRHOEA 7353 0.0114
577 DYSPNOEA 6448 0.0114
578 MUSCLE ATROPHY 144 0.0114
579 ABSCESS 181 0.0113
580 VENTRICULAR FIBRILLATION 126 0.0113
581 HYPERTHYROIDISM 164 0.0113
582 ASPIRATION 124 0.0113
583 PRODUCT USE COMPLAINT 178 0.0113
584 PNEUMONIA ASPIRATION 282 0.0113
585 BODY HEIGHT DECREASED 120 0.0112
586 CARDIO-RESPIRATORY ARREST 468 0.0112
587 ARRHYTHMIA 529 0.0112
588 INJECTION SITE IRRITATION 142 0.0111
589 HIATUS HERNIA 144 0.0111
590 DIVERTICULITIS 308 0.0111
591 NEURALGIA 270 0.0111
592 PSEUDOMONAS INFECTION 95 0.0111
593 BLOOD PRESSURE DECREASED 735 0.0111
594 PROTEINURIA 209 0.0110
595 MYOSITIS 98 0.0109
596 PALLOR 297 0.0109
597 PRODUCT DOSE OMISSION ISSUE 3195 0.0109
598 COAGULOPATHY 181 0.0109
599 CONDITION AGGRAVATED 3291 0.0108
600 ABDOMINAL PAIN 2517 0.0108
601 BURNING SENSATION 758 0.0108
602 INTENTIONAL DOSE OMISSION 308 0.0108
603 CARDIOGENIC SHOCK 155 0.0108
604 HYPOAESTHESIA 1614 0.0108
605 RHINORRHOEA 697 0.0108
606 PULMONARY CONGESTION 142 0.0108
607 HEART RATE INCREASED 1066 0.0107
608 CEREBRAL HAEMORRHAGE 385 0.0107
609 SHOCK 246 0.0107
610 HAIR COLOUR CHANGES 133 0.0107
611 CHEST DISCOMFORT 1091 0.0106
612 URINARY RETENTION 355 0.0106
613 CARDIOVASCULAR DISORDER 270 0.0106
614 MENTAL IMPAIRMENT 257 0.0106
615 RED BLOOD CELL COUNT DECREASED 303 0.0106
616 MUSCULOSKELETAL PAIN 555 0.0106
617 HEPATIC CYTOLYSIS 135 0.0106
618 VERTIGO 645 0.0106
619 SKIN LACERATION 115 0.0106
620 BLOOD ALKALINE PHOSPHATASE INCREASED 262 0.0105
621 PHARYNGEAL SWELLING 103 0.0105
622 GASTRIC HAEMORRHAGE 121 0.0105
623 CARDIAC ARREST 868 0.0105
624 PERITONITIS BACTERIAL 106 0.0105
625 BLISTER 587 0.0104
626 OXYGEN SATURATION DECREASED 587 0.0104
627 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 743 0.0104
628 ULCER 166 0.0104
629 HYPOCALCAEMIA 197 0.0104
630 MUSCLE TWITCHING 239 0.0104
631 MUSCULOSKELETAL DISORDER 197 0.0103
632 HYPOAESTHESIA ORAL 156 0.0103
633 BACTERIAL INFECTION 193 0.0103
634 LETHARGY 595 0.0103
635 RESPIRATORY DISORDER 309 0.0103
636 FIBROMYALGIA 251 0.0103
637 TOOTH INFECTION 136 0.0103
638 RESTLESS LEGS SYNDROME 187 0.0103
639 DEVICE BREAKAGE 416 0.0102
640 BACK PAIN 2379 0.0102
641 SMALL INTESTINAL OBSTRUCTION 126 0.0102
642 AGRANULOCYTOSIS 190 0.0102
643 FAECES DISCOLOURED 221 0.0102
644 HERNIA 197 0.0102
645 NEOPLASM 117 0.0102
646 ABDOMINAL DISCOMFORT 1707 0.0102
647 NASOPHARYNGITIS 1873 0.0102
648 WRONG TECHNIQUE IN DRUG USAGE PROCESS 369 0.0101
649 HEPATIC FAILURE 306 0.0101
650 THYROID CANCER 122 0.0101
651 TOXIC SKIN ERUPTION 102 0.0101
652 IMPAIRED DRIVING ABILITY 115 0.0101
653 SUDDEN DEATH 107 0.0101
654 LUNG INFECTION 157 0.0101
655 DYSPHONIA 591 0.0101
656 SWELLING 943 0.0101
657 RESPIRATORY DISTRESS 278 0.0101
658 THERAPEUTIC RESPONSE DECREASED 610 0.0101
659 DRUG EXPOSURE DURING PREGNANCY 342 0.0100
660 GASTROINTESTINAL DISORDER 899 0.0100
661 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 172 0.0100
662 JOINT DISLOCATION 106 0.0100
663 SOMNOLENCE 2011 0.0100
664 RASH MACULO-PAPULAR 222 0.0100
665 LOCAL SWELLING 174 0.0100
666 VIRAL INFECTION 331 0.0099
667 HEPATOCELLULAR INJURY 141 0.0099
668 GASTRIC ULCER 189 0.0099
669 SKIN INFECTION 111 0.0099
670 MULTI-ORGAN FAILURE 171 0.0099
671 HAEMOGLOBIN DECREASED 1014 0.0099
672 INTESTINAL OBSTRUCTION 372 0.0099
673 PERIPHERAL COLDNESS 135 0.0098
674 HOSPICE CARE 97 0.0098
675 SPINAL PAIN 115 0.0098
676 ADRENAL INSUFFICIENCY 119 0.0098
677 FEELING HOT 601 0.0098
678 SWOLLEN TONGUE 305 0.0098
679 DYSPHAGIA 926 0.0097
680 UPPER RESPIRATORY TRACT INFECTION 450 0.0097
681 GASTRIC DISORDER 334 0.0097
682 THINKING ABNORMAL 180 0.0097
683 BIPOLAR DISORDER 105 0.0096
684 FEMUR FRACTURE 299 0.0096
685 ASTHMA 1090 0.0096
686 DEVICE RELATED INFECTION 148 0.0096
687 SINUSITIS 985 0.0096
688 APHONIA 134 0.0096
689 HEART RATE DECREASED 337 0.0096
690 SKIN LESION 262 0.0095
691 HIP ARTHROPLASTY 146 0.0095
692 INFECTION 1376 0.0095
693 BONE DISORDER 173 0.0095
694 SKIN DISCOLOURATION 435 0.0095
695 IMPAIRED WORK ABILITY 201 0.0094
696 SLEEP DISORDER 663 0.0094
697 HAEMORRHOIDS 183 0.0094
698 MUSCLE SPASMS 1721 0.0094
699 METASTASES TO LIVER 164 0.0093
700 HEAD DISCOMFORT 165 0.0093
701 MOVEMENT DISORDER 299 0.0093
702 WHITE BLOOD CELL COUNT INCREASED 357 0.0093
703 CLOSTRIDIUM DIFFICILE INFECTION 203 0.0093
704 NEUTROPHIL COUNT INCREASED 95 0.0093
705 EJECTION FRACTION DECREASED 144 0.0093
706 CYST 115 0.0093
707 COGNITIVE DISORDER 432 0.0092
708 LYMPHOMA 142 0.0092
709 MULTIPLE ORGAN DYSFUNCTION SYNDROME 259 0.0091
710 LACRIMATION INCREASED 276 0.0091
711 FATIGUE 7108 0.0091
712 MUSCULOSKELETAL CHEST PAIN 141 0.0091
713 ANXIETY 2582 0.0091
714 DYSGEUSIA 670 0.0090
715 BLOOD PRESSURE FLUCTUATION 216 0.0090
716 DRY MOUTH 730 0.0090
717 OESOPHAGITIS 98 0.0090
718 BLOOD CREATINE PHOSPHOKINASE INCREASED 258 0.0090
719 RESTLESSNESS 327 0.0089
720 PRODUCT DOSE OMISSION IN ERROR 253 0.0089
721 CIRCULATORY COLLAPSE 152 0.0089
722 ANHEDONIA 234 0.0089
723 BLOOD URINE PRESENT 169 0.0089
724 MYALGIA 1512 0.0089
725 HEADACHE 5562 0.0089
726 HEPATITIS C 107 0.0089
727 NIGHT SWEATS 285 0.0088
728 TACHYCARDIA 781 0.0088
729 MICTURITION URGENCY 100 0.0087
730 PARAESTHESIA ORAL 126 0.0087
731 IMMUNE SYSTEM DISORDER 115 0.0087
732 INJECTION SITE URTICARIA 214 0.0087
733 EPISTAXIS 652 0.0087
734 CONTRAINDICATED PRODUCT ADMINISTERED 262 0.0086
735 INCORRECT DRUG ADMINISTRATION DURATION 242 0.0086
736 DISTURBANCE IN ATTENTION 464 0.0086
737 DRUG EFFECT DECREASED 463 0.0086
738 RASH PRURITIC 458 0.0084
739 BLOOD COUNT ABNORMAL 128 0.0084
740 PAIN 5171 0.0084
741 SCAB 96 0.0084
742 EYE SWELLING 313 0.0084
743 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 403 0.0084
744 PHARYNGEAL OEDEMA 129 0.0084
745 TASTE DISORDER 170 0.0084
746 JOINT RANGE OF MOTION DECREASED 112 0.0083
747 TENDON RUPTURE 103 0.0083
748 DEPRESSION 1895 0.0083
749 COVID-19 1457 0.0083
750 RESPIRATORY TRACT INFECTION 216 0.0083
751 HERPES ZOSTER 475 0.0083
752 THROMBOCYTOPENIA 924 0.0083
753 PYREXIA 2851 0.0082
754 EXPOSURE DURING PREGNANCY 512 0.0082
755 LIP SWELLING 274 0.0082
756 PULMONARY ARTERIAL HYPERTENSION 119 0.0082
757 ASPARTATE AMINOTRANSFERASE INCREASED 436 0.0082
758 ANGIOEDEMA 363 0.0082
759 LOWER RESPIRATORY TRACT INFECTION 373 0.0082
760 CHROMATURIA 185 0.0082
761 DRUG INEFFECTIVE 10789 0.0082
762 CONVULSION 468 0.0082
763 CHILLS 957 0.0082
764 CAESAREAN SECTION 95 0.0082
765 SKIN DISORDER 272 0.0081
766 CYANOSIS 128 0.0081
767 FULL BLOOD COUNT DECREASED 164 0.0081
768 GAMMA-GLUTAMYLTRANSFERASE INCREASED 180 0.0081
769 NECK PAIN 452 0.0081
770 POOR QUALITY SLEEP 174 0.0081
771 INSOMNIA 2147 0.0081
772 PROSTATIC SPECIFIC ANTIGEN INCREASED 111 0.0080
773 PREMATURE BABY 242 0.0080
774 HYPERCALCAEMIA 99 0.0080
775 DELIRIUM 278 0.0080
776 EAR INFECTION 213 0.0080
777 SEIZURE 924 0.0080
778 SKIN REACTION 112 0.0079
779 DEPRESSED MOOD 420 0.0079
780 PANCYTOPENIA 443 0.0079
781 HAIR TEXTURE ABNORMAL 106 0.0079
782 PULMONARY EMBOLISM 753 0.0079
783 INTRAOCULAR PRESSURE INCREASED 101 0.0079
784 C-REACTIVE PROTEIN INCREASED 287 0.0079
785 RESPIRATORY ARREST 217 0.0079
786 DEEP VEIN THROMBOSIS 511 0.0079
787 INTERSTITIAL LUNG DISEASE 380 0.0078
788 HAEMATOCHEZIA 432 0.0078
789 PRURITUS 3000 0.0078
790 MUSCLE TIGHTNESS 126 0.0078
791 ORAL PAIN 174 0.0078
792 BURSITIS 94 0.0077
793 MENTAL DISORDER 337 0.0077
794 BLOOD BILIRUBIN INCREASED 209 0.0077
795 OSTEOPOROSIS 318 0.0077
796 INJURY 543 0.0077
797 EYE PAIN 434 0.0077
798 NERVOUS SYSTEM DISORDER 240 0.0077
799 INJECTION SITE PRURITUS 512 0.0076
800 TOXIC EPIDERMAL NECROLYSIS 116 0.0076
801 INJECTION SITE RASH 234 0.0076
802 HEPATITIS 195 0.0076
803 HYPERSENSITIVITY 1414 0.0076
804 FRACTURE 144 0.0076
805 PLATELET COUNT DECREASED 810 0.0076
806 ALANINE AMINOTRANSFERASE INCREASED 465 0.0076
807 ANAPHYLACTIC REACTION 418 0.0076
808 MATERNAL EXPOSURE DURING PREGNANCY 673 0.0075
809 HALLUCINATION 569 0.0075
810 SKIN EXFOLIATION 636 0.0075
811 ARTHRALGIA 3119 0.0075
812 LIVER FUNCTION TEST ABNORMAL 218 0.0075
813 INFLUENZA LIKE ILLNESS 614 0.0075
814 JOINT SWELLING 899 0.0074
815 SINUS TACHYCARDIA 105 0.0074
816 COLITIS 280 0.0074
817 NASAL CONGESTION 434 0.0074
818 CHOKING 144 0.0074
819 AGITATION 542 0.0074
820 SWELLING FACE 479 0.0073
821 AGEUSIA 183 0.0073
822 OROPHARYNGEAL PAIN 677 0.0073
823 BODY TEMPERATURE INCREASED 149 0.0073
824 LUNG NEOPLASM MALIGNANT 300 0.0073
825 TENDONITIS 113 0.0073
826 ACUTE RESPIRATORY DISTRESS SYNDROME 129 0.0073
827 ERECTILE DYSFUNCTION 187 0.0073
828 RHEUMATOID ARTHRITIS 823 0.0072
829 TOOTH DISORDER 161 0.0072
830 DRUG-INDUCED LIVER INJURY 227 0.0072
831 ACTIVITIES OF DAILY LIVING IMPAIRED 143 0.0072
832 EAR PAIN 140 0.0072
833 OSTEOPENIA 109 0.0072
834 GINGIVAL BLEEDING 98 0.0072
835 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 239 0.0071
836 DRUG LEVEL INCREASED 117 0.0071
837 SKIN CANCER 152 0.0071
838 FACE OEDEMA 119 0.0070
839 PERICARDITIS 118 0.0070
840 ANOSMIA 101 0.0070
841 SUICIDE ATTEMPT 423 0.0070
842 CANDIDA INFECTION 117 0.0069
843 PARAESTHESIA 1081 0.0069
844 FREQUENT BOWEL MOVEMENTS 185 0.0068
845 THERAPEUTIC RESPONSE UNEXPECTED 307 0.0068
846 INFLAMMATION 353 0.0068
847 INJECTION SITE SWELLING 523 0.0068
848 BLOOD LACTATE DEHYDROGENASE INCREASED 108 0.0068
849 PAIN IN JAW 193 0.0068
850 LYMPHADENOPATHY 238 0.0067
851 SEROTONIN SYNDROME 129 0.0067
852 PNEUMOTHORAX 106 0.0067
853 BASAL CELL CARCINOMA 104 0.0067
854 TINNITUS 306 0.0067
855 IMMUNODEFICIENCY 99 0.0066
856 INSURANCE ISSUE 100 0.0065
857 URTICARIA 1084 0.0065
858 EPILEPSY 197 0.0064
859 MIDDLE INSOMNIA 120 0.0064
860 ANGER 217 0.0064
861 ABNORMAL BEHAVIOUR 254 0.0064
862 RASH 2793 0.0064
863 HEPATIC FUNCTION ABNORMAL 239 0.0064
864 INTENTIONAL OVERDOSE 409 0.0064
865 THROAT IRRITATION 286 0.0064
866 DYSKINESIA 258 0.0063
867 PLASMA CELL MYELOMA 246 0.0063
868 PREMATURE DELIVERY 100 0.0063
869 LIVER FUNCTION TEST INCREASED 134 0.0062
870 ILL-DEFINED DISORDER 379 0.0062
871 THROAT TIGHTNESS 168 0.0062
872 RASH PAPULAR 139 0.0062
873 PHOTOSENSITIVITY REACTION 102 0.0062
874 EYE PRURITUS 207 0.0062
875 PANIC ATTACK 224 0.0061
876 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 158 0.0061
877 CRYING 223 0.0061
878 DRUG DOSE OMISSION BY DEVICE 479 0.0061
879 STOMATITIS 370 0.0061
880 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 141 0.0060
881 SENSORY DISTURBANCE 97 0.0060
882 PERITONITIS 125 0.0060
883 HALLUCINATION, VISUAL 127 0.0060
884 DRY EYE 300 0.0060
885 RASH MACULAR 209 0.0060
886 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 424 0.0060
887 HEPATIC ENZYME INCREASED 405 0.0059
888 DRUG ERUPTION 105 0.0059
889 PNEUMONITIS 161 0.0059
890 FLUSHING 598 0.0059
891 JOINT STIFFNESS 154 0.0059
892 FOETAL EXPOSURE DURING PREGNANCY 477 0.0059
893 PSORIASIS 766 0.0059
894 BONE PAIN 343 0.0058
895 MULTIPLE FRACTURES 96 0.0058
896 PRODUCT PREPARATION ERROR 120 0.0058
897 HOT FLUSH 437 0.0058
898 PHOTOPHOBIA 109 0.0058
899 STEVENS-JOHNSON SYNDROME 128 0.0058
900 GENERALISED TONIC-CLONIC SEIZURE 95 0.0057
901 IRRITABILITY 344 0.0057
902 DRUG INTOLERANCE 551 0.0057
903 ABDOMINAL PAIN LOWER 143 0.0056
904 ERYTHEMA 1161 0.0056
905 ELECTROCARDIOGRAM QT PROLONGED 203 0.0056
906 IRRITABLE BOWEL SYNDROME 121 0.0056
907 TRANSAMINASES INCREASED 125 0.0056
908 HEPATIC CANCER 135 0.0056
909 RASH ERYTHEMATOUS 268 0.0056
910 PROCEDURAL PAIN 155 0.0056
911 THERAPY CESSATION 285 0.0055
912 MUSCULOSKELETAL STIFFNESS 486 0.0055
913 MOOD ALTERED 151 0.0055
914 INJECTION SITE REACTION 378 0.0055
915 DEATH 4703 0.0055
916 LYMPHOCYTE COUNT DECREASED 96 0.0054
917 DERMATITIS 113 0.0054
918 AGGRESSION 267 0.0053
919 BREAST CANCER 489 0.0052
920 MOUTH ULCERATION 110 0.0052
921 PAIN OF SKIN 140 0.0052
922 LEUKOPENIA 260 0.0052
923 LABORATORY TEST ABNORMAL 153 0.0052
924 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 95 0.0052
925 INJECTION SITE ERYTHEMA 641 0.0052
926 ALOPECIA 1004 0.0051
927 ADVERSE EVENT 470 0.0051
928 FEBRILE NEUTROPENIA 337 0.0051
929 ABORTION SPONTANEOUS 203 0.0051
930 SKIN FISSURES 99 0.0051
931 MIGRAINE 480 0.0050
932 LIVER INJURY 123 0.0050
933 CYTOKINE RELEASE SYNDROME 100 0.0050
934 BONE MARROW FAILURE 101 0.0050
935 MUCOSAL INFLAMMATION 130 0.0050
936 OVERDOSE 1066 0.0049
937 TOOTH LOSS 102 0.0049
938 NEUTROPHIL COUNT DECREASED 198 0.0049
939 ABNORMAL DREAMS 134 0.0048
940 OCULAR HYPERAEMIA 228 0.0048
941 NEUTROPENIA 635 0.0047
942 WHITE BLOOD CELL COUNT DECREASED 499 0.0046
943 GLOSSODYNIA 103 0.0046
944 PSYCHOTIC DISORDER 135 0.0046
945 THERAPY INTERRUPTED 326 0.0046
946 SUICIDAL IDEATION 402 0.0044
947 TOXICITY TO VARIOUS AGENTS 740 0.0044
948 PSORIATIC ARTHROPATHY 177 0.0044
949 EMOTIONAL DISORDER 134 0.0043
950 NIGHTMARE 150 0.0043
951 DISEASE PROGRESSION 511 0.0043
952 ADVERSE DRUG REACTION 387 0.0043
953 THERAPY NON-RESPONDER 191 0.0042
954 MALIGNANT NEOPLASM PROGRESSION 434 0.0042
955 DRY SKIN 561 0.0042
956 OSTEONECROSIS OF JAW 101 0.0041
957 ECZEMA 211 0.0040
958 EYE IRRITATION 232 0.0040
959 PRODUCT SUBSTITUTION ISSUE 232 0.0040
960 EMOTIONAL DISTRESS 485 0.0040
961 THERAPEUTIC PRODUCT EFFECT DECREASED 179 0.0040
962 SEDATION 104 0.0040
963 MOOD SWINGS 125 0.0039
964 DRUG EFFECT INCOMPLETE 141 0.0039
965 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 210 0.0038
966 NEOPLASM PROGRESSION 133 0.0038
967 VAGINAL HAEMORRHAGE 162 0.0037
968 ANAPHYLACTIC SHOCK 95 0.0037
969 SYSTEMIC LUPUS ERYTHEMATOSUS 130 0.0037
970 TARDIVE DYSKINESIA 103 0.0036
971 PRODUCT USE IN UNAPPROVED INDICATION 861 0.0035
972 PROSTATE CANCER 272 0.0034
973 MULTIPLE SCLEROSIS 161 0.0034
974 COLITIS ULCERATIVE 149 0.0033
975 RENAL CANCER 148 0.0031
976 INCORRECT ROUTE OF DRUG ADMINISTRATION 111 0.0031
977 INFUSION RELATED REACTION 203 0.0031
978 SKIN IRRITATION 140 0.0031
979 THERAPEUTIC RESPONSE SHORTENED 96 0.0029
980 SKIN BURNING SENSATION 196 0.0027
981 DISEASE RECURRENCE 127 0.0027
982 WITHDRAWAL SYNDROME 109 0.0026
983 NO ADVERSE EVENT 408 0.0022
984 TREATMENT FAILURE 177 0.0021
985 DRUG ABUSE 177 0.0021
986 MULTIPLE SCLEROSIS RELAPSE 143 0.0021
987 ACNE 153 0.0020
988 COMPLETED SUICIDE 166 0.0020
989 DEVICE DIFFICULT TO USE 129 0.0019
990 DRUG WITHDRAWAL SYNDROME 130 0.0015
991 DRUG DEPENDENCE 129 0.0008